Article Cited by others

MINI REVIEW

The dawn of hedgehog inhibitors: Vismodegib

Sandhiya Selvarajan, Melvin George, Kumar Srinivasamurthy Suresh, Dkhar Steven Aibor

Year : 2013| Volume: 4| Issue : 1 | Page no: 4-7

   This article has been cited by
 
1 Metformin influences drug sensitivity in pancreatic cancer cells
Saverio Candido,Stephen L. Abrams,Linda Steelman,Kvin Lertpiriyapong,Alberto M. Martelli,Lucio Cocco,Stefano Ratti,Matilde Y. Follo,Ramiro M. Murata,Pedro L. Rosalen,Paolo Lombardi,Giuseppe Montalto,Melchiorre Cervello,Agnieszka Gizak,Dariusz Rakus,Pann-Gill Suh,Massimo Libra,James A. McCubrey
Advances in Biological Regulation. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 The hedgehog pathway in nonalcoholic fatty liver disease
Mariana Verdelho Machado,Anna Mae Diehl
Critical Reviews in Biochemistry and Molecular Biology. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Correlation of gene expression and associated mutation profiles of APOBEC3A, APOBEC3B, REV1, UNG, and FHIT with chemosensitivity of cancer cell lines to drug treatment
Suleyman Vural,Richard Simon,Julia Krushkal
Human Genomics. 2018; 12(1)
[Pubmed]  [Google Scholar] [DOI]
4 Hedgehog-mesenchyme gene signature identifies bi-modal prognosis in luminal and basal breast cancer sub-types
Wandaliz Torres-García,Maribella Domenech
Mol. BioSyst.. 2017;
[Pubmed]  [Google Scholar] [DOI]
5 Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates
Fatma E. El-Khouly,Dannis G. van Vuurden,Thom Stroink,Esther Hulleman,Gertjan J. L. Kaspers,N. Harry Hendrikse,Sophie E. M. Veldhuijzen van Zanten
Frontiers in Oncology. 2017; 7
[Pubmed]  [Google Scholar] [DOI]
6 Molecular modeling study on resistance of WT/D473H SMO to antagonists LDE-225 and LEQ-506
Jing Tu,Jiao Jiao Li,Li Ting Song,Hong Lin Zhai,Juan Wang,Xiao Yun Zhang
Pharmacological Research. 2017;
[Pubmed]  [Google Scholar] [DOI]
7 MicroRNA-1271 inhibits proliferation and promotes apoptosis of multiple myeloma cells through inhibiting smoothened-mediated Hedgehog signaling pathway
Zhengwei Xu,Chen Huang,Dingjun Hao
Oncology Reports. 2017; 37(2): 1261
[Pubmed]  [Google Scholar] [DOI]
8 Possible antifibrotic effect of GDC-0449 (Vismodegib), a hedgehog-pathway inhibitor, in mice model of Schistosoma –induced liver fibrosis
Abeer A. Elhenawy,Rehab H. Ashour,Nairmen Nabih,Naglaa M. Shalaby,Nirmeen Megahed
Parasitology International. 2017;
[Pubmed]  [Google Scholar] [DOI]
9 Synthesis and Investigation of S-Substituted 2-Mercaptobenzoimidazoles as Inhibitors of Hedgehog Signaling
Simone Gräßle,Steven Susanto,Sonja Sievers,Emel Tavsan,Martin Nieger,Nicole Jung,Stefan Bräse
ACS Medicinal Chemistry Letters. 2017;
[Pubmed]  [Google Scholar] [DOI]
10 Genomic landscape of gastric cancer: molecular classification and potential targets
Jiawei Guo,Weiwei Yu,Hui Su,Xiufeng Pang
Science China Life Sciences. 2016;
[Pubmed]  [Google Scholar] [DOI]
11 CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway
Ju Chen,Haining Lv,Jinping Hu,Ming Ji,Nina Xue,Chao Li,Shuanggang Ma,Qin Zhou,Bin Lin,Yan Li,Shishan Yu,Xiaoguang Chen
Cancer Letters. 2016;
[Pubmed]  [Google Scholar] [DOI]
12 Mature salivary gland rests within sonic hedgehog–positive medulloblastoma: case report and insights into the molecular genetics and embryopathology of ectopic intracranial salivary gland analogs
Berje Shammassian,Sunil Manjila,Efrem Cox,Kaine Onwuzulike,Dehua Wang,Mark Rodgers,Duncan Stearns,Warren R. Selman
Journal of Neurosurgery: Pediatrics. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
13 Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer
Hideya Onishi,Akio Yamasaki,Makoto Kawamoto,Akira Imaizumi,Mitsuo Katano
Cancer Letters. 2016; 371(2): 143
[Pubmed]  [Google Scholar] [DOI]
14 Sonidegib: A Review in Locally Advanced Basal Cell Carcinoma
Celeste B. Burness,Lesley J. Scott
Targeted Oncology. 2016;
[Pubmed]  [Google Scholar] [DOI]
15 MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling
Jeongeun Hyun,Youngmi Jung
World Journal of Gastroenterology. 2016; 22(29): 6652
[Pubmed]  [Google Scholar] [DOI]
16 Hedgehog pathway overexpression in pancreatic cancer is abrogated by new-generation taxoid SB-T-1216
B Mohelnikova-Duchonova,M Kocik,B Duchonova,V Brynychova,M Oliverius,J Hlavsa,E Honsova,J Mazanec,Z Kala,I Ojima,D J Hughes,J E Doherty,H A Murray,M A Crockard,R Lemstrova,P Soucek
The Pharmacogenomics Journal. 2016;
[Pubmed]  [Google Scholar] [DOI]
17 Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
Daniel V.T. Catenacci,Melissa R. Junttila,Theodore Karrison,Nathan Bahary,Margit N. Horiba,Sreenivasa R. Nattam,Robert Marsh,James Wallace,Mark Kozloff,Lakshmi Rajdev,Deirdre Cohen,James Wade,Bethany Sleckman,Heinz-Josef Lenz,Patrick Stiff,Pankaj Kumar,Peng Xu,Les Henderson,Naoko Takebe,Ravi Salgia,Xi Wang,Walter M. Stadler,Frederic J. de Sauvage,Hedy L. Kindler
Journal of Clinical Oncology. 2015; 33(36): 4284
[Pubmed]  [Google Scholar] [DOI]
18 Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
Elisabetta Rovida,Barbara Stecca
Seminars in Cancer Biology. 2015; 35: 154
[Pubmed]  [Google Scholar] [DOI]
19 Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Mark A. Feitelson,Alla Arzumanyan,Rob J. Kulathinal,Stacy W. Blain,Randall F. Holcombe,Jamal Mahajna,Maria Marino,Maria L. Martinez-Chantar,Roman Nawroth,Isidro Sanchez-Garcia,Dipali Sharma,Neeraj K. Saxena,Neetu Singh,Panagiotis J. Vlachostergios,Shanchun Guo,Kanya Honoki,Hiromasa Fujii,Alexandros G. Georgakilas,Alan Bilsland,Amedeo Amedei,Elena Niccolai,Amr Amin,S. Salman Ashraf,Chandra S. Boosani,Gunjan Guha,Maria Rosa Ciriolo,Katia Aquilano,Sophie Chen,Sulma I. Mohammed,Asfar S. Azmi,Dipita Bhakta,Dorota Halicka,W. Nicol Keith,Somaira Nowsheen
Seminars in Cancer Biology. 2015; 35: S25
[Pubmed]  [Google Scholar] [DOI]
20 Cancer stem cell targeting: Are we there yet?
Yuchae Jung,Woo-Young Kim
Archives of Pharmacal Research. 2015; 38(3): 414
[Pubmed]  [Google Scholar] [DOI]
21 Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells
S-Y Ju,C-YF Huang,W-C Huang,Y Su
Cell Death and Disease. 2015; 6(7): e1801
[Pubmed]  [Google Scholar] [DOI]
22 Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) – gene transcription, cell cycle regulation, metabolism and intercellular communication
Håkon Reikvam,Michelle Hauge,Annette K Brenner,Kimberley Joanne Hatfield,Øystein Bruserud
Expert Review of Hematology. 2015; 8(3): 299
[Pubmed]  [Google Scholar] [DOI]
23 Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44+/Musashi-1+ gastric cancer stem cells
Min Xu,Aihua Gong,Hongqiong Yang,Suraj K. George,Zhijun Jiao,Hongmei Huang,Xiaomeng Jiang,Youli Zhang
Cancer Letters. 2015; 369(1): 124
[Pubmed]  [Google Scholar] [DOI]
24 Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells
Timothy L. Fitzgerald,Kvin Lertpiriyapong,Lucio Cocco,Alberto M. Martelli,Massimo Libra,Saverio Candido,Giuseppe Montalto,Melchiorre Cervello,Linda Steelman,Stephen L. Abrams,James A. McCubrey
Advances in Biological Regulation. 2015; 59: 65
[Pubmed]  [Google Scholar] [DOI]
25 Mann med stort hode, lærevansker og multiple basalcellekarsinomer
Charlotte von der Lippe,Ingrid Roscher,Hilde Nordgarden,Cecilie Rustad,Selma Mujezinovic Larsen,Even Mjøen,Åse Bratland
Tidsskrift for Den norske legeforening. 2014; 134(11): 1151
[Pubmed]  [Google Scholar] [DOI]
26 Sites of Basal Cell Carcinomas and Head and Neck Congenital Clefts
Giovanni Nicoletti,Federica Brenta,Alberto Malovini,Omar Jaber,Angela Faga
Plastic and Reconstructive Surgery Global Open. 2014; 2(6): e164
[Pubmed]  [Google Scholar] [DOI]
27 Pediatric adrenocortical tumors: diagnosis, management and advancements in the understanding of the genetic basis and therapeutic implications
Sonir R Antonini,Letícia F Leal,Marcelo M Cavalcanti
Expert Review of Endocrinology & Metabolism. 2014; 9(5): 445
[Pubmed]  [Google Scholar] [DOI]
28 NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer
Angela N. Flores,Niamh McDermott,Armelle Meunier,Laure Marignol
Nature Reviews Urology. 2014; 11(9): 499
[Pubmed]  [Google Scholar] [DOI]
29 An overview of current and future treatment options for chondrosarcoma
Chen-Ming Su,Yi-Chin Fong,Chih-Hsin Tang
Expert Opinion on Orphan Drugs. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
30 Cílená léčba karcinomu pankreatu - Minulost či budoucnost? | [Targeted treatment of pancreas carcinoma - Past or future?]
Hucl, T.
Gastroenterologie a Hepatologie. 2013; 67(5): 366-376
[Pubmed]  [Google Scholar]
31 The latest progress of anti-tumor drugs approved by FDA in 2012
Chen, L., Zou, X., Huang, W.-L.
Chinese Journal of New Drugs. 2013; 22(17): 1983-1993
[Pubmed]  [Google Scholar]
32 Novel agents and future prospects in the treatment of pancreatic adenocarcinoma: Highlights from the "2013 ASCO Annual Meeting". Chicago, IL, USA; May 30 - June 4, 2013
Sarris, E.G. and Syrigos, K.N. and Wasif Saif, M.
Journal of the Pancreas. 2013; 14(4): 395-400
[Pubmed]  [Google Scholar]
33 Pushing tumor cells towards a malignant phenotype: Stimuli from the microenvironment, intercellular communications, and alternative roads
Fabrizio Marcucci,Matteo Bellone,Carmelo Antonio Caserta,Angelo Corti
International Journal of Cancer. 2013; : n/a
[Pubmed]  [Google Scholar] [DOI]
34 Ocular tumors: Triumphs, challenges and controversies
Ralph C. Eagle
Saudi Journal of Ophthalmology. 2013; 27(3): 129
[Pubmed]  [Google Scholar] [DOI]

 

Read this article